• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Abstract IA03: Genetic and non-genetic risk factors of pancreatic cancer
In the United States, incidence and mortality rates of pancreatic cancer (PC) have remained largely unchanged since 1973. During 2005-2009, the incidence rate for Whites was 11.6/105 and for African-Americans, 15.2/105. Mortality rates were 10.7/105 for Whites and 13.8/105 for African-Americans. The 5-year survival has been 4-7% for decades. The absolute number of new cases and deaths due to PC has been increasing steadily since 2004 due to the baby-boomer generation reaching the risk window (where median age at diagnosis is 71 years). By 2030, PC will be the second most common cause of cancer mortality, after lung cancer....
Source: Cancer Research - December 13, 2016 Category: Cancer & Oncology Authors: Gloria M. Petersen Tags: Epidemiology and Risk Factors Source Type: research

Abstract P2-12-02: Axillary reverse mapping: A feasibility study
ConclusionThe identification rate of ARM lymphatics and nodes is low when only blue dye is used. The method appears it to be oncologically safe in patients with low tumour burden. However there is need for further studies will before this procedure can be universally applied without compromising the oncologic safety.Once the technique is proven to be oncologically safe even in a selected group of patients, a large randomized trial will be needed to give a satisfactory answer whether the problem of lymphedema be eliminated or minimized in the patients in whom arm lymphatics are successfully preserved.Citation Format: Khare ...
Source: Cancer Research - February 18, 2016 Category: Cancer & Oncology Authors: Khare, S., Singh, G., Das, A., Bal, A. Tags: Poster Session Abstracts Source Type: research

Abstract P2-01-15: Noninvasive assessment of axillary lymph node metastases in breast cancer using EpCAM antibody
Conclusion:The NIR dye labeled EpCAM antibody (anti-EpCAM/Cy7) has a high accuracy in evaluating the axillary lymph node status of breast cancer in the animal experiment. Our tiny preclinical experiment showed the value of using EpCAM antibody as a new method for noninvasive lymph node evaluation for breast cancer and potentially extended in a lot of other epithelial originated cancers. Citation Format: Shu Wang, Jiajia Guo, Liulu Zhang, Houpu Yang. Noninvasive assessment of axillary lymph node metastases in breast cancer using EpCAM antibody [abstract]. In: Proceedings of the Thirty-Seventh Annual CTRC-AACR San Antonio Br...
Source: Cancer Research - April 30, 2015 Category: Cancer & Oncology Authors: Wang, S., Guo, J., Zhang, L., Yang, H. Tags: Poster Session Abstracts Source Type: research

Abstract P6-08-39: Influence of lifestyle factors and tumor cell dissemination in 632 early breast cancer patients
Conclusion: Lifestyle factors seems to influence the outcome in our cohort of EBC patients as shown in previous studies. Final data and results regarding to tumor cell dissemination compared to lifestyle behaviour will be available for the SABCS 2014. Citation Format: Bahriye Aktas, Anna Frackenpohl, Siegfried Hauch, Johann Kraus, Hans Armin Kestler, Rainer Klaus Kimmig, Sabine Kasimir-Bauer. Influence of lifestyle factors and tumor cell dissemination in 632 early breast cancer patients [abstract]. In: Proceedings of the Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2014 Dec 9-13; San Antonio, TX. Ph...
Source: Cancer Research - April 30, 2015 Category: Cancer & Oncology Authors: Aktas, B., Frackenpohl, A., Hauch, S., Kraus, J., Kestler, H. A., Kimmig, R. K., Kasimir-Bauer, S. Tags: Poster Session Abstracts Source Type: research